585 related articles for article (PubMed ID: 32266063)
1. Current understanding of metal ions in the pathogenesis of Alzheimer's disease.
Wang L; Yin YL; Liu XZ; Shen P; Zheng YG; Lan XR; Lu CB; Wang JZ
Transl Neurodegener; 2020; 9():10. PubMed ID: 32266063
[TBL] [Abstract][Full Text] [Related]
2. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
Wang P; Wang ZY
Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
[TBL] [Abstract][Full Text] [Related]
3. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
4. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
Guan PP; Cao LL; Wang P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
6. Se-Methylselenocysteine Ameliorates Neuropathology and Cognitive Deficits by Attenuating Oxidative Stress and Metal Dyshomeostasis in Alzheimer Model Mice.
Xie Y; Liu Q; Zheng L; Wang B; Qu X; Ni J; Zhang Y; Du X
Mol Nutr Food Res; 2018 Jun; 62(12):e1800107. PubMed ID: 29688618
[TBL] [Abstract][Full Text] [Related]
7. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
9. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
10. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
11. Roles of glycogen synthase kinase 3 in Alzheimer's disease.
Cai Z; Zhao Y; Zhao B
Curr Alzheimer Res; 2012 Sep; 9(7):864-79. PubMed ID: 22272620
[TBL] [Abstract][Full Text] [Related]
12. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
[TBL] [Abstract][Full Text] [Related]
13. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
14. Aβ and Tau Interact with Metal Ions, Lipid Membranes and Peptide-Based Amyloid Inhibitors: Are These Common Features Relevant in Alzheimer's Disease?
Di Natale G; Sabatino G; Sciacca MFM; Tosto R; Milardi D; Pappalardo G
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014310
[TBL] [Abstract][Full Text] [Related]
15. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
16. Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer's Disease: Role of Glutathione and Metal Ions.
Roy RG; Mandal PK; Maroon JC
ACS Chem Neurosci; 2023 Sep; 14(17):2944-2954. PubMed ID: 37561556
[TBL] [Abstract][Full Text] [Related]
17. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
18. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
19. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
Zhu C; Xu B; Sun X; Zhu Q; Sui Y
Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
